Search Within

Radiology, Department of

  1. "Executive Committee, Center for Hematologic Malignancies"
Formats
  1. Journal Article (54)
  2. Meeting Abstract (49)
Groups
  1. Center for Hematologic Malignancies (103)
  2. Executive Committee, Center for Hematologic Malignancies (103)
  3. Department of Medicine (100)
  4. Hematologic Malignancies, Division of (97)
  5. GSK Faculty (74)
  6. Molecular Imaging and Therapy Service (67)

More Groups

People
  1. Anas Younes (35)
  2. Andrew Zelenetz (32)
  3. Matthew Matasar (32)
  4. Heiko Schoder (29)
  5. Anita Kumar (28)
  6. Alison Moskowitz (27)

More People

Years
  1. 2024 (4)
  2. 2023 (3)
  3. 2022 (7)
  4. 2021 (3)
  5. 2020 (8)
  6. 2019 (10)

More Years

Publications
  1. Blood (20)
  2. Journal of Clinical Oncology (8)
  3. Hematological Oncology (6)
  4. Cancer Research (5)
  5. Journal of Nuclear Medicine (5)
  6. Pediatric Blood and Cancer (5)

More Publications

Publishers
  1. American Society of Hematology (20)
  2. Nature Publishing Group (13)
  3. American Society of Clinical Oncology (11)
  4. American Association for Cancer Research (9)
  5. Wiley Blackwell (9)
  6. Society of Nuclear Medicine (5)

More Publishers

Results (103)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • uPAR immuno-PET in pancreatic cancer, aging, and chemotherapy-induced senescence
    Journal Article

    Pratt, E. C.; Mezzadra, R.; Kulick, A.; Kaminsky, S.; Samuels, Z. V.; Loor, A.; de Stanchina, E.; Lowe, S. W.; Lewis, J. S.
    Journal of Nuclear Medicine (2024)

    Fulltext@MSK | Save
  • Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
    Journal Article

    Friedman, J. S.; Durham, B. H.; Reiner, A. S.; Yabe, M.; Petrova-Drus, K.; Dogan, A.; Pulitzer, M.; Busam, K. J.; Francis, J. H.; Rampal, R. K.; more...
    British Journal of Haematology (2024)

    Fulltext@MSK | Save
  • Immunochemotherapy plus lenalidomide for high-risk mantle cell lymphoma with measurable residual disease evaluation
    Journal Article

    Epstein-Peterson, Z. D.; Drill, E.; Aypar, U.; Batlevi, C. L.; Caron, P.; Dogan, A.; Drullinsky, P.; Gerecitano, J.; Hamlin, P. A.; Ho, C.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Diffuse large B-cell lymphoma involving osseous sites: Utility of response assessment by PET/CT and good long-term outcomes
    Journal Article

    Ghione, P.; Ahsanuddin, S.; Luttwak, E.; Varela, S. B.; Nakajima, R.; Michaud, L.; Gupta, K.; Navitski, A.; Straus, D.; Palomba, M. L.; more...
    Haematologica (2024)

    Fulltext@MSK | Save
  • Phase 2 trial of single-agent cobimetinib for adults with histiocytic neoplasms
    Meeting Abstract

    Diamond, E. L.; Durham, B.; Dogan, A.; Yabe, M.; Petrova-Drus, K.; Rampal, R. K.; Ulaner, G.; Lacouture, M.; Rotemberg, V.; Covey, A.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Outcomes of patients with positive interim positron emission tomography (PET) continuing ABVD in the clinical setting
    Journal Article

    Zheng, S.; Gupta, K.; Goyal, P.; Nakajima, R.; Michaud, L.; Batlevi, C. L.; Hamlin, P. A.; Horwitz, S.; Kumar, A.; Matasar, M. J.; more...
    Cancers (2023)

    Fulltext@MSK | Save
  • Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Targeting pancreatic cancer senescence with ImmunoPET
    Meeting Abstract

    Pratt, E. C.; Mezzadra, R.; Viray, T.; Kaminsky, S.; Lowe, S. W.; Lewis, J. S.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
    Journal Article

    Jee, J.; Lebow, E. S.; Yeh, R.; Das, J. P.; Namakydoust, A.; Paik, P. K.; Chaft, J. E.; Jayakumaran, G.; Brannon, A. R.; Benayed, R.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • ARAF protein kinase activates RAS by antagonizing its binding to RASGAP NF1
    Journal Article

    Su, W.; Mukherjee, R.; Yaeger, R.; Son, J.; Xu, J.; Na, N.; Timaul, N. M.; Hechtman, J.; Paroder, V.; Lin, M.; more...
    Molecular Cell (2022)

    Fulltext@MSK | Save